Arterial Desaturation Syndrome Following Pleurodesis with Talc Slurry: Incidence, Clinical Features, and Outcome

Cancer Investigation

Volumn 21, Issue 6, 2003, Pages 848-854

  Bondoc, Anna York P ^a   Bach, Peter B ^a   Sklarin, Nancy T ^a   Vander Els, Nicholas J ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE   (United States)

Author keywords

ARDS after talc pleurodesis; Malignant pleural effusions; Talc pleurodesis

Indexed keywords

CORTICOSTEROID; TALC;

ADULT; ARTERIAL DESATURATION SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; BREAST CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CONVALESCENCE; DRUG MEGADOSE; DYSPNEA; FEMALE; FEVER; HIGH RISK PATIENT; HUMAN; INCIDENCE; MALE; OVARY CANCER; OXYGEN SUPPLY; PLEURA EFFUSION; PLEURODESIS; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK FACTOR; SYMPTOMATOLOGY; THORAX PAIN; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ARTERIES; DYSPNEA; FEMALE; HUMANS; MALE; MIDDLE AGED; OVARIAN NEOPLASMS; OXYGEN INHALATION THERAPY; PLEURAL EFFUSION; PLEURODESIS; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; RISK FACTORS; SYNDROME; TALC;

EID: 0346096832     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120025087     Document Type: Article

References (13)

1. Kennedy, L.; Sahn, S.A. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 1994, 106, 1215-1222.
2. Viallat, J.R.; Rey, F.; Astoul, P.; Boutin, C. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases. Chest 1996, 110, 1387-1393.
3. Heffner, J.E.; Standerfer, R.J.; Torstveit, J.; Unruh, L. Clinical efficacy of doxycycline for pleurodesis. Chest 1994, 105, 1743-1747.
4. Sahn, S.A.; Light, R.W. Pro/Con editorials: talc should be used for pleurodesis/talc should not be used for pleurodesis. Am. J. Respir. Crit. Care Med. 2000, 162, 2023-2026.
5. Rinaldo, J.E.; Owens, G.R.; Rogers, R.M. Adult respiratory distress syndrome following intrapleural administration of talc. J. Thorac. Cardiovasc. Surg. 1983, 85, 523-526.
6. Bouchama, A.; Chastre, J.; Gaudichet, A.; Soler, P.; Gibert, C. Acute pneumonitis with bilateral pleural effusion after talc pleurodesis. Chest 1984, 86, 795-797.
7. Rehse, D.H.; Aye, R.W.; Florence, M.G. Respiratory failure following talc pleurodesis. Am. J. Surg. 1999, 177, 437-440.
8. Campos, J.R.; Werebe, E.C.; Vargas, F.S.; Jatene, F.B.; Light, R.W. Respiratory failure due to insufflated talc. Lancet 1997, 349, 251-252.
9. van den Heuvel, M.M.; Smit, H.J.; Barbierato, S.B.; Havenith, C.E.; Beelen, R.H.; Postmus, P.E. Talc-induced inflammation in the pleural cavity. Eur. Respir. J. 1998, 12(6), 1419-1423.
10. Kennedy, L.; Harley, R.A.; Sahn, S.A.; Strange, C. Talc slurry pleurodesis. Pleural fluid and histologic analysis. Chest 1995, 107, 1707-1712.
11. Xie, C.; Texeira, L.R.; McGovern, J.P.; Light, R.W. Systemic corticosteroids decrease the effectiveness of talc pleurodesis. Am. J. Respir. Crit. Care Med. 1998, 157, 1441-1444.
12. Weissberg, D.; Ben-Zeev, I. Talc pleurodesis. Experience with 360 cases. J. Thorac. Cardiovasc. Surg. 1993, 106, 689-695.
13. Werebe, E.C.; Pazetti, R.; Milanez de Campos, J.R.; Fernandez, P.P.; Capelozzi, V.L.; Jatene, F.B.; Vargas, F.S. Systemic distribution of talc after intrapleural administration in rats. Chest 1999, 115, 190-193.